According to prior large-scale genomic investigations (Cancer Genome Atlas Network 2012; Lu et al. 2019; Nagahashi et al. 2016), well-known driver gene mutations including APC, TP53, SMAD4, PIK3CA, and KRAS, are significantly involved in the tumorigenesis of CRC. This evidence concerns the gene TP53 and colorectal carcinoma.